Search Results - Abrahamsen, Timothy

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Design and Rationale of the LAPLACE‐TIMI 57 Trial: A Phase II, Double‐Blind, Placebo‐Controlled Study of the Efficacy and Tolerability of a Monoclonal Antibody Inhibitor of PCSK9 in Subjects With Hypercholesterolemia on Background Statin Therapy

    Design and Rationale of the LAPLACE‐TIMI 57 Trial: A Phase II, Double‐Blind, Placebo‐Controlled Study of the Efficacy and Tolerability of a Monoclonal Antibody Inhibitor of PCSK9 i... by Kohli, Payal, Desai, Nihar R., Giugliano, Robert P., Kim, Jae B., Somaratne, Ransi, Huang, Fannie, Knusel, Beat, McDonald, Shannon, Abrahamsen, Timothy, Wasserman, Scott M., Scott, Robert, Sabatine, Marc S.

    Published 2012
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  2. 2
    Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 in combination with a statin in patients with hypercholesterolaemia (LAPLACE-TIMI 57): a randomised, placebo-controlled, dose-ranging, phase 2 study

    Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 in combination with a statin in patients with hypercholesterolaemia (LA... by Giugliano, Robert P, Desai, Nihar R, Kohli, Payal, Rogers, William J, Somaratne, Ransi, Huang, Fannie, Liu, Thomas, Mohanavelu, Satishkumar, Hoffman, Elaine B, McDonald, Shannon T, Abrahamsen, Timothy E, Wasserman, Scott M, Scott, Robert, Sabatine, Marc S

    Published 2012
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:

Search Tools: